カテゴリー： 世界, 医療/バイオ, LP Information

世界のウィルソン病用診断市場予測 2023年-2029年

【英語タイトル】Global Wilson’s Disease Diagnostic Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02204）・商品コード：LP23DC02204
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のウィルソン病用診断市場」は、過去の販売実績から2022年の世界のウィルソン病用診断の総販売量を検討し、2023年から2029年の予測されるウィルソン病用診断の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のウィルソン病用診断の市場規模を掲載し、XXX百万米ドル規模の世界のウィルソン病用診断市場の詳細な分析を提供します。本インサイトレポートは、世界のウィルソン病用診断業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のウィルソン病用診断市場における各社の独自のポジションをより深く理解するために、ウィルソン病用診断製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のウィルソン病用診断市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ウィルソン病用診断の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ウィルソン病用診断の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ウィルソン病用診断のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ウィルソン病用診断の世界主要メーカーとしては、Orphalan、 AstraZeneca、 Vivet Therapeutics、 Pfizer、 Ultragenyx Pharmaceutical、 Valeant Pharmaceuticals International, Inc.、 Noblepharma Co., Ltd.、 Merck & Co., Inc.、 Teva Pharmaceuticals、 Wilson Therapeutics ABなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のウィルソン病用診断市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではウィルソン病用診断市場をセグメンテーションし、種類別 (ペニシラミン、トリエンチン、テトラチオモリブデン酸)、用途別 (病院薬局、オンライン薬局、小売薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ペニシラミン、トリエンチン、テトラチオモリブデン酸

・用途別区分：病院薬局、オンライン薬局、小売薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のウィルソン病用診断市場の10年間の市場状況・展望は？
・世界および地域別に見たウィルソン病用診断市場成長の要因は何か？
・ウィルソン病用診断の市場機会はエンドマーケットの規模によってどのように変化するのか？
・ウィルソン病用診断のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ウィルソン病用診断の年間販売量2018-2029、地域別現状・将来分析
・ウィルソン病用診断の種類別セグメント：ペニシラミン、トリエンチン、テトラチオモリブデン酸
・ウィルソン病用診断の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ウィルソン病用診断の用途別セグメント：病院薬局、オンライン薬局、小売薬局
・ウィルソン病用診断の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のウィルソン病用診断市場
・企業別のグローバルウィルソン病用診断市場データ：2018-2023年の年間販売量、市場シェア
・企業別のウィルソン病用診断の年間売上：2018-2023年の売上、市場シェア
・企業別のウィルソン病用診断販売価格
・主要企業のウィルソン病用診断生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ウィルソン病用診断の地域別レビュー
・地域別のウィルソン病用診断市場規模2018-2023：年間販売量、売上
・主要国別のウィルソン病用診断市場規模2018-2023：年間販売量、売上
・南北アメリカのウィルソン病用診断販売の成長
・アジア太平洋のウィルソン病用診断販売の成長
・ヨーロッパのウィルソン病用診断販売の成長
・中東・アフリカのウィルソン病用診断販売の成長

南北アメリカ市場
・南北アメリカの国別のウィルソン病用診断販売量、売上（2018-2023）
・南北アメリカのウィルソン病用診断の種類別販売量
・南北アメリカのウィルソン病用診断の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のウィルソン病用診断販売量、売上（2018-2023）
・アジア太平洋のウィルソン病用診断の種類別販売量
・アジア太平洋のウィルソン病用診断の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のウィルソン病用診断販売量、売上（2018-2023）
・ヨーロッパのウィルソン病用診断の種類別販売量
・ヨーロッパのウィルソン病用診断の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のウィルソン病用診断販売量、売上（2018-2023）
・中東・アフリカのウィルソン病用診断の種類別販売量
・中東・アフリカのウィルソン病用診断の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ウィルソン病用診断の製造コスト構造分析
・ウィルソン病用診断の製造プロセス分析
・ウィルソン病用診断の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ウィルソン病用診断の主要なグローバル販売業者
・ウィルソン病用診断の主要なグローバル顧客

地域別のウィルソン病用診断市場予測レビュー
・地域別のウィルソン病用診断市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ウィルソン病用診断の種類別市場規模予測
・ウィルソン病用診断の用途別市場規模予測

主要企業分析
Orphalan、 AstraZeneca、 Vivet Therapeutics、 Pfizer、 Ultragenyx Pharmaceutical、 Valeant Pharmaceuticals International, Inc.、 Noblepharma Co., Ltd.、 Merck & Co., Inc.、 Teva Pharmaceuticals、 Wilson Therapeutics AB
・企業情報
・ウィルソン病用診断製品
・ウィルソン病用診断販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Wilson’s Disease Diagnostic market size is projected to grow from US$ 575.4 million in 2022 to US$ 759.5 million in 2029; it is expected to grow at a CAGR of 4.0% from 2023 to 2029.
United States market for Wilson’s Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Wilson’s Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Wilson’s Disease Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Wilson’s Disease Diagnostic players cover Orphalan, AstraZeneca, Vivet Therapeutics, Pfizer, Ultragenyx Pharmaceutical, Valeant Pharmaceuticals International, Inc., Noblepharma Co., Ltd., Merck & Co., Inc. and Teva Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Wilson’s disease diagnostics market refers to the market for diagnostic tests and tools used to diagnose Wilson’s disease, a rare genetic disorder that causes the accumulation of copper in the body. The diagnostic tests are used to measure the level of copper in the blood, urine, or liver, and to evaluate the function of the liver.
LPI (LP Information)’ newest research report, the “Wilson’s Disease Diagnostic Industry Forecast” looks at past sales and reviews total world Wilson’s Disease Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Wilson’s Disease Diagnostic sales for 2023 through 2029. With Wilson’s Disease Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Wilson’s Disease Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Wilson’s Disease Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Wilson’s Disease Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Wilson’s Disease Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Wilson’s Disease Diagnostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Wilson’s Disease Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Wilson’s Disease Diagnostic market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Penicillamine
Trientine
Tetrathiomolybdate
Segmentation by application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Orphalan
AstraZeneca
Vivet Therapeutics
Pfizer
Ultragenyx Pharmaceutical
Valeant Pharmaceuticals International, Inc.
Noblepharma Co., Ltd.
Merck & Co., Inc.
Teva Pharmaceuticals
Wilson Therapeutics AB
Key Questions Addressed in this Report
What is the 10-year outlook for the global Wilson’s Disease Diagnostic market?
What factors are driving Wilson’s Disease Diagnostic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Wilson’s Disease Diagnostic market opportunities vary by end market size?
How does Wilson’s Disease Diagnostic break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Wilson’s Disease Diagnostic Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Wilson’s Disease Diagnostic by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Wilson’s Disease Diagnostic by Country/Region, 2018, 2022 & 2029
2.2 Wilson’s Disease Diagnostic Segment by Type
2.2.1 Penicillamine
2.2.2 Trientine
2.2.3 Tetrathiomolybdate
2.3 Wilson’s Disease Diagnostic Sales by Type
2.3.1 Global Wilson’s Disease Diagnostic Sales Market Share by Type (2018-2023)
2.3.2 Global Wilson’s Disease Diagnostic Revenue and Market Share by Type (2018-2023)
2.3.3 Global Wilson’s Disease Diagnostic Sale Price by Type (2018-2023)
2.4 Wilson’s Disease Diagnostic Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Wilson’s Disease Diagnostic Sales by Application
2.5.1 Global Wilson’s Disease Diagnostic Sale Market Share by Application (2018-2023)
2.5.2 Global Wilson’s Disease Diagnostic Revenue and Market Share by Application (2018-2023)
2.5.3 Global Wilson’s Disease Diagnostic Sale Price by Application (2018-2023)
3 Global Wilson’s Disease Diagnostic by Company
3.1 Global Wilson’s Disease Diagnostic Breakdown Data by Company
3.1.1 Global Wilson’s Disease Diagnostic Annual Sales by Company (2018-2023)
3.1.2 Global Wilson’s Disease Diagnostic Sales Market Share by Company (2018-2023)
3.2 Global Wilson’s Disease Diagnostic Annual Revenue by Company (2018-2023)
3.2.1 Global Wilson’s Disease Diagnostic Revenue by Company (2018-2023)
3.2.2 Global Wilson’s Disease Diagnostic Revenue Market Share by Company (2018-2023)
3.3 Global Wilson’s Disease Diagnostic Sale Price by Company
3.4 Key Manufacturers Wilson’s Disease Diagnostic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Wilson’s Disease Diagnostic Product Location Distribution
3.4.2 Players Wilson’s Disease Diagnostic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Wilson’s Disease Diagnostic by Geographic Region
4.1 World Historic Wilson’s Disease Diagnostic Market Size by Geographic Region (2018-2023)
4.1.1 Global Wilson’s Disease Diagnostic Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Wilson’s Disease Diagnostic Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Wilson’s Disease Diagnostic Market Size by Country/Region (2018-2023)
4.2.1 Global Wilson’s Disease Diagnostic Annual Sales by Country/Region (2018-2023)
4.2.2 Global Wilson’s Disease Diagnostic Annual Revenue by Country/Region (2018-2023)
4.3 Americas Wilson’s Disease Diagnostic Sales Growth
4.4 APAC Wilson’s Disease Diagnostic Sales Growth
4.5 Europe Wilson’s Disease Diagnostic Sales Growth
4.6 Middle East & Africa Wilson’s Disease Diagnostic Sales Growth
5 Americas
5.1 Americas Wilson’s Disease Diagnostic Sales by Country
5.1.1 Americas Wilson’s Disease Diagnostic Sales by Country (2018-2023)
5.1.2 Americas Wilson’s Disease Diagnostic Revenue by Country (2018-2023)
5.2 Americas Wilson’s Disease Diagnostic Sales by Type
5.3 Americas Wilson’s Disease Diagnostic Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Wilson’s Disease Diagnostic Sales by Region
6.1.1 APAC Wilson’s Disease Diagnostic Sales by Region (2018-2023)
6.1.2 APAC Wilson’s Disease Diagnostic Revenue by Region (2018-2023)
6.2 APAC Wilson’s Disease Diagnostic Sales by Type
6.3 APAC Wilson’s Disease Diagnostic Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Wilson’s Disease Diagnostic by Country
7.1.1 Europe Wilson’s Disease Diagnostic Sales by Country (2018-2023)
7.1.2 Europe Wilson’s Disease Diagnostic Revenue by Country (2018-2023)
7.2 Europe Wilson’s Disease Diagnostic Sales by Type
7.3 Europe Wilson’s Disease Diagnostic Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Wilson’s Disease Diagnostic by Country
8.1.1 Middle East & Africa Wilson’s Disease Diagnostic Sales by Country (2018-2023)
8.1.2 Middle East & Africa Wilson’s Disease Diagnostic Revenue by Country (2018-2023)
8.2 Middle East & Africa Wilson’s Disease Diagnostic Sales by Type
8.3 Middle East & Africa Wilson’s Disease Diagnostic Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Wilson’s Disease Diagnostic
10.3 Manufacturing Process Analysis of Wilson’s Disease Diagnostic
10.4 Industry Chain Structure of Wilson’s Disease Diagnostic
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Wilson’s Disease Diagnostic Distributors
11.3 Wilson’s Disease Diagnostic Customer
12 World Forecast Review for Wilson’s Disease Diagnostic by Geographic Region
12.1 Global Wilson’s Disease Diagnostic Market Size Forecast by Region
12.1.1 Global Wilson’s Disease Diagnostic Forecast by Region (2024-2029)
12.1.2 Global Wilson’s Disease Diagnostic Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Wilson’s Disease Diagnostic Forecast by Type
12.7 Global Wilson’s Disease Diagnostic Forecast by Application
13 Key Players Analysis
13.1 Orphalan
13.1.1 Orphalan Company Information
13.1.2 Orphalan Wilson’s Disease Diagnostic Product Portfolios and Specifications
13.1.3 Orphalan Wilson’s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Orphalan Main Business Overview
13.1.5 Orphalan Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Wilson’s Disease Diagnostic Product Portfolios and Specifications
13.2.3 AstraZeneca Wilson’s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Vivet Therapeutics
13.3.1 Vivet Therapeutics Company Information
13.3.2 Vivet Therapeutics Wilson’s Disease Diagnostic Product Portfolios and Specifications
13.3.3 Vivet Therapeutics Wilson’s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Vivet Therapeutics Main Business Overview
13.3.5 Vivet Therapeutics Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Wilson’s Disease Diagnostic Product Portfolios and Specifications
13.4.3 Pfizer Wilson’s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Ultragenyx Pharmaceutical
13.5.1 Ultragenyx Pharmaceutical Company Information
13.5.2 Ultragenyx Pharmaceutical Wilson’s Disease Diagnostic Product Portfolios and Specifications
13.5.3 Ultragenyx Pharmaceutical Wilson’s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ultragenyx Pharmaceutical Main Business Overview
13.5.5 Ultragenyx Pharmaceutical Latest Developments
13.6 Valeant Pharmaceuticals International, Inc.
13.6.1 Valeant Pharmaceuticals International, Inc. Company Information
13.6.2 Valeant Pharmaceuticals International, Inc. Wilson’s Disease Diagnostic Product Portfolios and Specifications
13.6.3 Valeant Pharmaceuticals International, Inc. Wilson’s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Valeant Pharmaceuticals International, Inc. Main Business Overview
13.6.5 Valeant Pharmaceuticals International, Inc. Latest Developments
13.7 Noblepharma Co., Ltd.
13.7.1 Noblepharma Co., Ltd. Company Information
13.7.2 Noblepharma Co., Ltd. Wilson’s Disease Diagnostic Product Portfolios and Specifications
13.7.3 Noblepharma Co., Ltd. Wilson’s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Noblepharma Co., Ltd. Main Business Overview
13.7.5 Noblepharma Co., Ltd. Latest Developments
13.8 Merck & Co., Inc.
13.8.1 Merck & Co., Inc. Company Information
13.8.2 Merck & Co., Inc. Wilson’s Disease Diagnostic Product Portfolios and Specifications
13.8.3 Merck & Co., Inc. Wilson’s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Merck & Co., Inc. Main Business Overview
13.8.5 Merck & Co., Inc. Latest Developments
13.9 Teva Pharmaceuticals
13.9.1 Teva Pharmaceuticals Company Information
13.9.2 Teva Pharmaceuticals Wilson’s Disease Diagnostic Product Portfolios and Specifications
13.9.3 Teva Pharmaceuticals Wilson’s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Teva Pharmaceuticals Main Business Overview
13.9.5 Teva Pharmaceuticals Latest Developments
13.10 Wilson Therapeutics AB
13.10.1 Wilson Therapeutics AB Company Information
13.10.2 Wilson Therapeutics AB Wilson’s Disease Diagnostic Product Portfolios and Specifications
13.10.3 Wilson Therapeutics AB Wilson’s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Wilson Therapeutics AB Main Business Overview
13.10.5 Wilson Therapeutics AB Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Wilson’s Disease Diagnostic Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Wilson’s Disease Diagnostic Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Penicillamine
Table 4. Major Players of Trientine
Table 5. Major Players of Tetrathiomolybdate
Table 6. Global Wilson’s Disease Diagnostic Sales by Type (2018-2023) & (K Units)
Table 7. Global Wilson’s Disease Diagnostic Sales Market Share by Type (2018-2023)
Table 8. Global Wilson’s Disease Diagnostic Revenue by Type (2018-2023) & ($ million)
Table 9. Global Wilson’s Disease Diagnostic Revenue Market Share by Type (2018-2023)
Table 10. Global Wilson’s Disease Diagnostic Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Wilson’s Disease Diagnostic Sales by Application (2018-2023) & (K Units)
Table 12. Global Wilson’s Disease Diagnostic Sales Market Share by Application (2018-2023)
Table 13. Global Wilson’s Disease Diagnostic Revenue by Application (2018-2023)
Table 14. Global Wilson’s Disease Diagnostic Revenue Market Share by Application (2018-2023)
Table 15. Global Wilson’s Disease Diagnostic Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Wilson’s Disease Diagnostic Sales by Company (2018-2023) & (K Units)
Table 17. Global Wilson’s Disease Diagnostic Sales Market Share by Company (2018-2023)
Table 18. Global Wilson’s Disease Diagnostic Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Wilson’s Disease Diagnostic Revenue Market Share by Company (2018-2023)
Table 20. Global Wilson’s Disease Diagnostic Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Wilson’s Disease Diagnostic Producing Area Distribution and Sales Area
Table 22. Players Wilson’s Disease Diagnostic Products Offered
Table 23. Wilson’s Disease Diagnostic Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Wilson’s Disease Diagnostic Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Wilson’s Disease Diagnostic Sales Market Share Geographic Region (2018-2023)
Table 28. Global Wilson’s Disease Diagnostic Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Wilson’s Disease Diagnostic Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Wilson’s Disease Diagnostic Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Wilson’s Disease Diagnostic Sales Market Share by Country/Region (2018-2023)
Table 32. Global Wilson’s Disease Diagnostic Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Wilson’s Disease Diagnostic Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Wilson’s Disease Diagnostic Sales by Country (2018-2023) & (K Units)
Table 35. Americas Wilson’s Disease Diagnostic Sales Market Share by Country (2018-2023)
Table 36. Americas Wilson’s Disease Diagnostic Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Wilson’s Disease Diagnostic Revenue Market Share by Country (2018-2023)
Table 38. Americas Wilson’s Disease Diagnostic Sales by Type (2018-2023) & (K Units)
Table 39. Americas Wilson’s Disease Diagnostic Sales by Application (2018-2023) & (K Units)
Table 40. APAC Wilson’s Disease Diagnostic Sales by Region (2018-2023) & (K Units)
Table 41. APAC Wilson’s Disease Diagnostic Sales Market Share by Region (2018-2023)
Table 42. APAC Wilson’s Disease Diagnostic Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Wilson’s Disease Diagnostic Revenue Market Share by Region (2018-2023)
Table 44. APAC Wilson’s Disease Diagnostic Sales by Type (2018-2023) & (K Units)
Table 45. APAC Wilson’s Disease Diagnostic Sales by Application (2018-2023) & (K Units)
Table 46. Europe Wilson’s Disease Diagnostic Sales by Country (2018-2023) & (K Units)
Table 47. Europe Wilson’s Disease Diagnostic Sales Market Share by Country (2018-2023)
Table 48. Europe Wilson’s Disease Diagnostic Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Wilson’s Disease Diagnostic Revenue Market Share by Country (2018-2023)
Table 50. Europe Wilson’s Disease Diagnostic Sales by Type (2018-2023) & (K Units)
Table 51. Europe Wilson’s Disease Diagnostic Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Wilson’s Disease Diagnostic Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Wilson’s Disease Diagnostic Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Wilson’s Disease Diagnostic Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Wilson’s Disease Diagnostic Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Wilson’s Disease Diagnostic Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Wilson’s Disease Diagnostic Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Wilson’s Disease Diagnostic
Table 59. Key Market Challenges & Risks of Wilson’s Disease Diagnostic
Table 60. Key Industry Trends of Wilson’s Disease Diagnostic
Table 61. Wilson’s Disease Diagnostic Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Wilson’s Disease Diagnostic Distributors List
Table 64. Wilson’s Disease Diagnostic Customer List
Table 65. Global Wilson’s Disease Diagnostic Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Wilson’s Disease Diagnostic Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Wilson’s Disease Diagnostic Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Wilson’s Disease Diagnostic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Wilson’s Disease Diagnostic Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Wilson’s Disease Diagnostic Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Wilson’s Disease Diagnostic Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Wilson’s Disease Diagnostic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Wilson’s Disease Diagnostic Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Wilson’s Disease Diagnostic Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Wilson’s Disease Diagnostic Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Wilson’s Disease Diagnostic Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Wilson’s Disease Diagnostic Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Wilson’s Disease Diagnostic Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Orphalan Basic Information, Wilson’s Disease Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 80. Orphalan Wilson’s Disease Diagnostic Product Portfolios and Specifications
Table 81. Orphalan Wilson’s Disease Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Orphalan Main Business
Table 83. Orphalan Latest Developments
Table 84. AstraZeneca Basic Information, Wilson’s Disease Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 85. AstraZeneca Wilson’s Disease Diagnostic Product Portfolios and Specifications
Table 86. AstraZeneca Wilson’s Disease Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. AstraZeneca Main Business
Table 88. AstraZeneca Latest Developments
Table 89. Vivet Therapeutics Basic Information, Wilson’s Disease Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 90. Vivet Therapeutics Wilson’s Disease Diagnostic Product Portfolios and Specifications
Table 91. Vivet Therapeutics Wilson’s Disease Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Vivet Therapeutics Main Business
Table 93. Vivet Therapeutics Latest Developments
Table 94. Pfizer Basic Information, Wilson’s Disease Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Wilson’s Disease Diagnostic Product Portfolios and Specifications
Table 96. Pfizer Wilson’s Disease Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Ultragenyx Pharmaceutical Basic Information, Wilson’s Disease Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 100. Ultragenyx Pharmaceutical Wilson’s Disease Diagnostic Product Portfolios and Specifications
Table 101. Ultragenyx Pharmaceutical Wilson’s Disease Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Ultragenyx Pharmaceutical Main Business
Table 103. Ultragenyx Pharmaceutical Latest Developments
Table 104. Valeant Pharmaceuticals International, Inc. Basic Information, Wilson’s Disease Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 105. Valeant Pharmaceuticals International, Inc. Wilson’s Disease Diagnostic Product Portfolios and Specifications
Table 106. Valeant Pharmaceuticals International, Inc. Wilson’s Disease Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Valeant Pharmaceuticals International, Inc. Main Business
Table 108. Valeant Pharmaceuticals International, Inc. Latest Developments
Table 109. Noblepharma Co., Ltd. Basic Information, Wilson’s Disease Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 110. Noblepharma Co., Ltd. Wilson’s Disease Diagnostic Product Portfolios and Specifications
Table 111. Noblepharma Co., Ltd. Wilson’s Disease Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Noblepharma Co., Ltd. Main Business
Table 113. Noblepharma Co., Ltd. Latest Developments
Table 114. Merck & Co., Inc. Basic Information, Wilson’s Disease Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 115. Merck & Co., Inc. Wilson’s Disease Diagnostic Product Portfolios and Specifications
Table 116. Merck & Co., Inc. Wilson’s Disease Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Merck & Co., Inc. Main Business
Table 118. Merck & Co., Inc. Latest Developments
Table 119. Teva Pharmaceuticals Basic Information, Wilson’s Disease Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 120. Teva Pharmaceuticals Wilson’s Disease Diagnostic Product Portfolios and Specifications
Table 121. Teva Pharmaceuticals Wilson’s Disease Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Teva Pharmaceuticals Main Business
Table 123. Teva Pharmaceuticals Latest Developments
Table 124. Wilson Therapeutics AB Basic Information, Wilson’s Disease Diagnostic Manufacturing Base, Sales Area and Its Competitors
Table 125. Wilson Therapeutics AB Wilson’s Disease Diagnostic Product Portfolios and Specifications
Table 126. Wilson Therapeutics AB Wilson’s Disease Diagnostic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Wilson Therapeutics AB Main Business
Table 128. Wilson Therapeutics AB Latest Developments
List of Figures
Figure 1. Picture of Wilson’s Disease Diagnostic
Figure 2. Wilson’s Disease Diagnostic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Wilson’s Disease Diagnostic Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Wilson’s Disease Diagnostic Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Wilson’s Disease Diagnostic Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Penicillamine
Figure 10. Product Picture of Trientine
Figure 11. Product Picture of Tetrathiomolybdate
Figure 12. Global Wilson’s Disease Diagnostic Sales Market Share by Type in 2022
Figure 13. Global Wilson’s Disease Diagnostic Revenue Market Share by Type (2018-2023)
Figure 14. Wilson’s Disease Diagnostic Consumed in Hospital Pharmacies
Figure 15. Global Wilson’s Disease Diagnostic Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 16. Wilson’s Disease Diagnostic Consumed in Online Pharmacies
Figure 17. Global Wilson’s Disease Diagnostic Market: Online Pharmacies (2018-2023) & (K Units)
Figure 18. Wilson’s Disease Diagnostic Consumed in Retail Pharmacies
Figure 19. Global Wilson’s Disease Diagnostic Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 20. Global Wilson’s Disease Diagnostic Sales Market Share by Application (2022)
Figure 21. Global Wilson’s Disease Diagnostic Revenue Market Share by Application in 2022
Figure 22. Wilson’s Disease Diagnostic Sales Market by Company in 2022 (K Units)
Figure 23. Global Wilson’s Disease Diagnostic Sales Market Share by Company in 2022
Figure 24. Wilson’s Disease Diagnostic Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Wilson’s Disease Diagnostic Revenue Market Share by Company in 2022
Figure 26. Global Wilson’s Disease Diagnostic Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Wilson’s Disease Diagnostic Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Wilson’s Disease Diagnostic Sales 2018-2023 (K Units)
Figure 29. Americas Wilson’s Disease Diagnostic Revenue 2018-2023 ($ Millions)
Figure 30. APAC Wilson’s Disease Diagnostic Sales 2018-2023 (K Units)
Figure 31. APAC Wilson’s Disease Diagnostic Revenue 2018-2023 ($ Millions)
Figure 32. Europe Wilson’s Disease Diagnostic Sales 2018-2023 (K Units)
Figure 33. Europe Wilson’s Disease Diagnostic Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Wilson’s Disease Diagnostic Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Wilson’s Disease Diagnostic Revenue 2018-2023 ($ Millions)
Figure 36. Americas Wilson’s Disease Diagnostic Sales Market Share by Country in 2022
Figure 37. Americas Wilson’s Disease Diagnostic Revenue Market Share by Country in 2022
Figure 38. Americas Wilson’s Disease Diagnostic Sales Market Share by Type (2018-2023)
Figure 39. Americas Wilson’s Disease Diagnostic Sales Market Share by Application (2018-2023)
Figure 40. United States Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Wilson’s Disease Diagnostic Sales Market Share by Region in 2022
Figure 45. APAC Wilson’s Disease Diagnostic Revenue Market Share by Regions in 2022
Figure 46. APAC Wilson’s Disease Diagnostic Sales Market Share by Type (2018-2023)
Figure 47. APAC Wilson’s Disease Diagnostic Sales Market Share by Application (2018-2023)
Figure 48. China Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Wilson’s Disease Diagnostic Sales Market Share by Country in 2022
Figure 56. Europe Wilson’s Disease Diagnostic Revenue Market Share by Country in 2022
Figure 57. Europe Wilson’s Disease Diagnostic Sales Market Share by Type (2018-2023)
Figure 58. Europe Wilson’s Disease Diagnostic Sales Market Share by Application (2018-2023)
Figure 59. Germany Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Wilson’s Disease Diagnostic Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Wilson’s Disease Diagnostic Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Wilson’s Disease Diagnostic Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Wilson’s Disease Diagnostic Sales Market Share by Application (2018-2023)
Figure 68. Egypt Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Wilson’s Disease Diagnostic Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Wilson’s Disease Diagnostic in 2022
Figure 74. Manufacturing Process Analysis of Wilson’s Disease Diagnostic
Figure 75. Industry Chain Structure of Wilson’s Disease Diagnostic
Figure 76. Channels of Distribution
Figure 77. Global Wilson’s Disease Diagnostic Sales Market Forecast by Region (2024-2029)
Figure 78. Global Wilson’s Disease Diagnostic Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Wilson’s Disease Diagnostic Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Wilson’s Disease Diagnostic Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Wilson’s Disease Diagnostic Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Wilson’s Disease Diagnostic Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のウィルソン病用診断市場予測 2023年-2029年] (コード：LP23DC02204)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のウィルソン病用診断市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の動物疾患診断アナライザー市場予測 2023年-2029年
  • 世界の副甲状腺疾患治療市場予測 2023年-2029年
  • 世界の医薬品用脂質市場予測 2023年-2029年
  • 世界の肢先端脳梁症候群治療市場予測 2023年-2029年
  • 世界のプロスタサイクリン受容体作動薬市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆